Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.625
Bid: 0.60
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.05 (8.333%)
Open: 0.625
High: 0.625
Low: 0.625
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: N4's Nuvec success; Watkin Jones tumbles

Tue, 04th Oct 2022 11:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

N4 Pharma PLC, up 10% at 2.20 pence, 12-month range 1.50p-8.69p. The company announces two successful in vitro tests of Nuvec when loaded with two small interfering siRNA probes. siRNA can prevent cells from communicating, and could potentially prevent cancer cells from replicating. After announcing in September that it would focus on developing multiple loaded siRNA on Nuvec, N4 says it has now completed in vitro testing, which shows both probes were able to "significantly silence" their respective targets.

----------

AIM - LOSERS

----------

Watkin Jones PLC, down 33% at 101.69p, 12-month range 97.30p-282.08p. It expects to miss full-year profit expectations. The London-based student accommodation developer and manager says that in the first half to September 30, cost inflation was mitigated by increasing asset values, however in the second half it sees some pricing and margin "softness" on sales. It adds that two forward sales which were expected to close in September have been impacted by recent market volatility, and are now expected to go through in financial year 2023.

----------

Allergy Therapeutics PLC, down 11% at 17.00p, 12-month range 15.25p-40.50p. It pauses production at the Freeman facility, part of its Worthing, UK manufacturing site. Allergy Therapeutics says that the facility has been closed to accelerate ongoing site improvements.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2019 13:18

N4 Pharma Raises GBP1.1 Million In Share Placing To Fund Nuvec System (ALLISS)

LONDON (Alliance News) - N4 Pharma PLC on Firday said it raised GBP1.1 million in a placing of 10.5 million shares at 10 pence each.N4 Pharma shares were trading down 18% at 10.10p each on

Read more
8 Feb 2019 12:00

N4 Pharma raises £1.05m in placing to advance vaccine delivery system

(Sharecast News) - Specialist pharmaceutical company N4 Pharma said on Friday that it has raised £1.05m before expenses in a placing of 10.5m new ordinary shares to fund its vaccine delivery system.

Read more
20 Dec 2018 15:06

N4 Pharma extends 'Nuvec' licence agreement with Aussie university firm

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has extended the terms of its licence agreement with UniQuest - a University of Queensland company - for the exploitation of its novel delivery system 'Nuvec' on Thursday.

Read more
28 Nov 2018 11:30

N4 Pharma bears more good news on its Nuvec particles

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated on the latest key research findings for its 'Nuvec' delivery system on Wednesday.

Read more
28 Nov 2018 11:20

N4 Pharma Shares Boosted By Positive Nuvec System Results

LONDON (Alliance News) - N4 Pharma PLC shares were up on Wednesday after encouraging research on its Nuvec delivery system.Shares in the pharma company were up 26% at 10.74 pence on Nuvec a

Read more
5 Nov 2018 10:57

WINNERS & LOSERS SUMMARY: Micro Focus Rises On Outlook And Buyback

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Micro Focus up

Read more
29 Oct 2018 11:32

N4 Pharma pleased with latest test results on 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated the market on the latest key research findings for its 'Nuvec' delivery system on Monday, reporting that the Nuvec particles had a "clear adjuvant effect" to help deliver a level of immune response for both the mRNA and pDNA OVA antigens, comparable to that of existing delivery systems.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 09:46

N4 Pharma Shares Rise Following Positive Research Results For Nuvec

LONDON (Alliance News) - Shares rose in N4 Pharma PLC on Monday as a key research study demonstrated positive results for the company's Nuvec delivery system.Shares in the vaccine and a

Read more
2 Oct 2018 12:08

N4 Pharma Commissions Research Programme With Gowans Laboratory

LONDON (Alliance News) - N4 Pharma PLC said Tuesday it commissioned a research program with the Gowans laboratory in the University of Adelaide to investigate its Nuvec system's potential to a

Read more
24 Sep 2018 10:48

WINNERS & LOSERS SUMMARY: Thomas Cook Slumps After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Sky,

Read more
20 Sep 2018 10:30

N4 Pharma To Close Generic Unit After Failed Trials; Loss Narrows

LONDON (Alliance News) - Shares in N4 Pharma PLC dropped on Thursday as the company said it will close its Generic unit after the failure of Sildenafil trials.Shares in the pharmaceutical a

Read more
20 Sep 2018 10:30

WINNERS & LOSERS SUMMARY: Rio Tinto Up On Plan To Return Sale Proceeds

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Rio up 1.9%.

Read more
20 Sep 2018 09:49

N4 Pharma calls it a day on generics division, losses widen

(Sharecast News) - After undertaking a strategic review, N4 Pharma directors have decided to discontinue further development of Sildenafil and shutter the rest of its generics division.

Read more
9 Jul 2018 10:08

WINNERS & LOSERS SUMMARY: Centamin Falls After Gold Production Drops

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Just up 2.4%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.